Search results
Double Dare host Marc Summers gives update on years-long battle with cancer
The US Sun· 3 days agoDOUBLE Dare host Marc Summers has given an update on his battle with cancer in an exclusive...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 1 day agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Is Bristol Myers Squibb Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 6 days agoIt's a promising blockbuster drug that could generate $4 billion in sales at its peak. In March, the FDA granted accelerated approval for Breyanzi, a...
Signaturefd LLC Purchases 867 Shares of Galapagos NV (NASDAQ:GLPG)
ETF DAILY NEWS· 9 hours agoSignaturefd LLC raised its position in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 78.6% in the fourth quarter, according to the company in its most recent filing with the Securities ...
Super Senior: Newton Baker
WCAX-TV Vermont· 6 days agoFrom piano to poetry to long-distance running, Newton Baker finds fun with everything he takes on.
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 1 day agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023 ...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 2 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 7 days agoStockNews.com assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research note issued to investors on Wednesday morning. The brokerage issued a hold rating ...
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest...
Morningstar· 7 days agoSUZHOU, China and ROCKVILLE, Md., April 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis ...
Critical Survey: Coeptis Therapeutics (COEP) versus The Competition
ETF DAILY NEWS· 7 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 289 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We ...
